
CareDx
Innovative noninvasive testing solutions enhancing transplant patient outcomes throughout their journey.








USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 54 % | 9 % | (13 %) | 19 % | 11 % | 15 % | 13 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (10 %) | (24 %) | 5 % | (39 %) | 9 % | 14 % | 18 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (10 %) | (24 %) | (68 %) | 16 % | (5 %) | 2 % | 7 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 26 % | 28 % | 29 % | 22 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
CareDx is a healthcare company focused on improving outcomes for transplant patients through innovative, noninvasive testing solutions and services. The company operates in the transplant care market, providing a range of products and services designed to support patients, caregivers, and healthcare providers. CareDx's offerings include kidney transplant services, next-generation HLA typing for organ matching, and digital transplant administration solutions. Additionally, the company collaborates with biopharma partners to accelerate clinical development through its pharma services. CareDx generates revenue by offering these specialized testing and management solutions, which are critical for the ongoing care and monitoring of transplant patients. The company's business model is centered around providing comprehensive, patient-centric care that spans the entire transplant journey, from pre-transplant diagnostics to post-transplant monitoring and support. CareDx serves a diverse client base, including transplant patients, caregivers, healthcare providers, and biopharma companies. The company's innovative approach and commitment to personalized care make it a leader in the transplant care industry.
Keywords: transplant care, noninvasive testing, kidney transplant, HLA typing, digital solutions, patient monitoring, biopharma services, clinical development, personalized care, healthcare innovation.
Tech stack
Investments by CareDx
Edit



